Functional Brain Imaging and Employment in First-Episode Psychotic Patients Treated With Risperdal

Stopped early · Phase 4

Conditions studied: Schizophrenia

In brief

Assured treatment with Risperal CONSTA will provide first-episode patients, who have a greater potential for therapeutic response, with their best opportunity for continued improvement in cognitive function beyond three months of treatment.

Key facts

Study ID

NCT00314613

Run by

Duke University

People needed

30

Starts

2006-04-01

Last updated by the study team

2017-12-02

Who can join

Age: 18 and older, up to 40. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• male or female between 18-40 years of age
• meet DSM-IV criteria for first-episode schizophreniform, schizophrenia or schizoaffective disorder

You may not qualify if…

• pregnant \& breast-feeding women
• patients with known sensitivity to oral Risperdal

Where it is running

• John Umstead Hospital — Butner, North Carolina, United States
• Duke University Medical Center — Durham, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.